Co-expression correlation was found between MZF1 and CDC37 in CRPC patient samples (Spearman’s rank correlation score: 0.78) and in prostate adenocarcinoma patient samples (Spearman’s correlation: 0.41) (Figure 1G,H). This evidence concerns the gene MZF1 and prostate adenocarcinoma.